Leap Therapeutics and EORTC to initiate combination trial of oncology drugs

US-based biotechnology firm Leap Therapeutics has entered an immunotherapy collaboration with Belgian European Organisation for the Research and Treatment of Cancer (EORTC) to conduct a clinical trial of DKN-01 to treat advanced biliary tract cancers …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news